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GastroparesisAbstract The present work deals with various attempts to prepare a gastroretentive formulation of
lacidipine for treating gastroparesis. High density sucrose beads were modiﬁed by coating with cer-
tain polymers, but unfortunately sustained release could not be achieved. Granules were prepared by
wet granulation technology using different combinations of polymers and a release of the drug was
observed. The method failed to release the drug as per desired speciﬁcations. Polymeric coating fol-
lowed by wet granulation was thought to be a better process to sustain the dissolution rate. The
release rate can be modiﬁed by the incorporation of different polymeric coatings, but the mucoad-
hesive potential of granules was only 4.23% which might be due to its large size and the presence
294 S. Sultana et al.of other ingredients. Further, the lacidipine loaded microparticles were prepared by different meth-
ods such as compression, ionic gelation with TPP, ionic gelation with TPP and glutaraldehyde, spray
drying and coacervation techniques. The formulations were evaluated for average particle size, sur-
face morphology, entrapment efﬁciency, % yield and mucoadhesive potential. The microparticles
prepared by compression method using HPMC K4M and SCMC as mucoadhesive polymers and
BaSO4 as high density diluent showed poor bioadhesion (8.3%) and poor release characteristics
(100% in 120 min). Ionic gelation with tripolyphosphate yielded microspheres with poor mechanical
strength. In order to improve its mechanical strength, TPP ionic gelation was combined with step-
wise cross-linking with glutaraldehyde. The additional solidiﬁcation step to improve mechanical
strength left this procedure tedious, time consuming and cytotoxic. Spray drying method gave a very
low yield with 46.67% bioadhesion. The method using CaCl2 for ionotropic gelation showed the best
results with regard to physical characteristics (well formed discrete, spherical surface microcapsule),
particle size (88.57 ± 0.51), in vitro bioadhesion (67.33%), yield (>85%) and loading (>70%).
ª 2013 Production and hosting by Elsevier B.V. on behalf of King Saud University.1. Introduction
Gastroparesis is one of the most severe and complicated gastric
motility disorders. Ordinarily, strong muscular contractions
propel food through the digestive tract. But in gastroparesis,
the muscles in the wall of the stomach do not contract properly
which the affect gastric emptying process (Bouras and Scolapio,
2004). In some cases, the pylorus does not open spontaneously
or frequently enough which results in indigestion, nausea and
vomiting. Gastroparesis is complicated to treat and the treat-
ment options are limited. There are few available medications
which provide symptomatic control rather than dealing with
the underlying problem, slowacting and are associatedwith seri-
ous side effects. For this reason, they are often ineffective. Cal-
cium channel blockers have a dilation effect on smooth muscles
and thus can enhance gastric emptying in patients suffering from
gastroparesis if targeted to the pylorus (Sultana et al., 2009).
Such an effect can be attained by developing a high-density
mucoadhesive drug delivery system, which can be retained at
the site of action or near the pylorus and provide sustained local
drug delivery. The mucoadhesive polymer selected should have
strong hydrogen bonding groups, strong anionic charges, high
chain ﬂexibility required for penetration, surface tension that fa-
vors spreading of their chain into mucin network with high
molecular weight. These polymer characteristics coupled with
their high-density approach could solve the targeting purpose
to pylorus with prolonged absorption at the desired site.
Targeted formulation for treating gastroparesis can be pre-
pared using different polymers and drug delivery system. In
the present work, a wide variety of natural and synthetic bio-
degradable polymers such as hydroxypropyl methylcellulose
(HPMC), sodium carboxy methylcellulose (SCMC), polyvinyl
pyrrolidone (PVP), alginate and chitosan were investigated to
obtain optimistic formulation. However, the main concern is
toward chitosan and alginate owing to its non-toxicity, biodeg-
radation and bioadhesion like properties. Chitosan obtained
by the deacetylation of chitin, carries a positive charge capable
of interacting with the negative charge mucin. It has been
investigated for its possible role in controlling the delivery of
active medicaments, which is ascribable to its unique gel
forming ability. Positively charged microparticles enhance its
mucoadhesive properties and make chitosan suitable for deliv-
ery of drugs via the nasal or the gastrointestinal route
(He et al., 1999).The drug delivery system enough to fulﬁll the demand includes
beads, granules and microparticles due to the small size when
compared with tablets that favor better targeting, adhesion, pen-
etration and localized drug delivery with prolonged action (Choy
et al., 2011; Mohammed et al., 2010; Dettmar et al., 2001).
Differentmethods can be utilized to prepare beads or microparti-
cles such as solvent evaporation (Trivedi et al., 2008), precipita-
tion polymerization method (Flake et al., 2011), chemical
denaturation (Sultana et al., 2009), spray drying (Oliveira et al.,
2005), emulsion droplet coalescence (Tokumitsu et al., 1999),
ionotropic gelation (Prasanth et al., 2009; Silva et al., 2006) and
the thermal crosslinkingmethod (Sinha et al., 2004).Themucoad-
hesive potential varies with the type of cross-linking agent and the
extent of crosslinking between the polymeric molecules.
In this study, an attempt has beenmade to formulate the gas-
troretentive drug delivery system of lacidipine (calcium channel
blocker) which is a potent vasodilator. A variety of mucoadhe-
sive and high density polymers were chosen and implemented. A
comparison between different formulationswasmade on the ba-
sis of% yield, entrapment efﬁciency, release proﬁle, and in vitro
mucoadhesion in order to groom optimistic formulation.
2. Materials and methods
2.1. Materials
Lacidipine was received as a gift sample from Ranbaxy Re-
search laboratory (Gurgaon, India; average M.W. 455.5).
Chitosan (75% medium deacetylated) was purchased from Sig-
ma Aldrich (Bangalore, India). Medium viscosity sodium algi-
nate was procured from Merck, India (2% w/v solution 5000
cp). Eudrajit RL 100 and HPMC K4M were received as a gift
sample from Dr. Reddy’s Laboratory (Bangalore, India). Glu-
taraldehyde (25% w/v) and sodium carboxy methylcellulose
(SCMC) was purchased from S.D Fine Chem Ltd. Calcium
chloride (CaCl2.2H2O), Span 80, TPP (tripoly phosphate),
Tween 80 was obtained from the Central Drug House, India.
All other chemicals and reagents were of analytical grade.
2.2. Methods
2.2.1. Preparation of high-density sucrose beads
Drug was coated on high-density sucrose beads (1 mm) by two
methods: (a) adsorption method and (b) coating method.
Table 1 Composition of coating polymers for the preparation
of high density beads (per 500 mg sucrose beads).
S. No. Ingredients I II III IV V VI VII
1 Eudragit L100 – – – 60 80 – 80
2 Ehylcellulose 90 80 70 40 20 – –
3 HPMC 10 20 30 – – 100 –
4 PVP K30 – – – – – – 20
5 Ethanol q.s – q.s q.s q.s q.s q.s
Lacidipine loaded gastroretentive formulation 295Adsorption method involves the adsorption of SCMC (2%)
and Eudragit (2%) on sucrose beads received as a gift sample
from Panacea Biotech. Ltd. (Mumbai, India). Lacidipine
(2 mg) was dissolved in a polymeric solution (2% SCMC
and Eudragit in ethanol). The same solution (0.5 mL) was al-
lowed to adsorb on 500 mg sucrose beads and dried at 60 C
temperature in an oven. For the coating method, a coating
solution was prepared and coated on sucrose bead by a spray
gun (pressure: 30 kg/cm2; nozzle size 1 mm) in a coating pan.
Different compositions of polymeric solution (% w/w) as
shown in Table 1 were coated on sucrose beads until the weight
of the beads was increased to 5%. The temperature of the
blown air was maintained at 60 C.
2.2.2. Preparation of granules
Granules were prepared by wet granulation technology (Table
2). Lacidipine (0.5% w/w), dibasic calcium phosphate and
magnesium stearate were passed through 80 mesh. The
weighed quantities of ingredients were mixed thoroughly in a
dry blender and the required quantity of granulating agent
(hydroalcohlic solution of HPC, Eudrajit, and EC) as speciﬁed
in Table 2 was added slowly. Ethanol was mixed in portions
until a slightly cohesive product was formed. The cohesive
product was passed through an extruder and the extruded
material was chopped to produce slugs having a diameter ofTable 2 Composition of ingredients for the preparation of high de
S. No. Ingredients I II III
1 Lacidipine 2 2 2
2 DCP q.s q.s q.s
3 HPMC K4M 20 20 20
4 Eudrajit L100 – – –
5 Ethylcellulose 3 5 10
6 HPC – – –
7 Magnesium stearate 1 1 1
Ethanol q.s q.s q.s
All ingredients were expressed in % w/w.
DCP, dibasic calcium phosphate; HPMC, hydroxypropyl methylcellulose
Table 3 Composition of coating polymers to prepare high density
S. No. Ingredients I II III
1 HPC 100 85 75
2 Eudragit L100 – – –
3 EC – 15 25
4 HPMC K100 – – –
5 Ethanol q.s q.s q.sabout 1 mm and a length of 2–3 mm. The slugs were then
spheronised by passage through a spheroniser, and the
particles thus formed were dried to constant weight at 60 C.
The dried particles were sieved to separate those having diam-
eters between 0.7 and 1.5 mm.
2.2.3. Preparation of coated granules
Lacidipine (0.5% w/w), hydroxymethylcellulose (10% w/w),
dibasic calcium phosphate (83.5% w/w) and magnesium stea-
rate (1% w/w) were mixed together by doubling up in a dry
blender. Ethanol was added in portions until a slightly cohe-
sive product was formed. The mixture was then extruded,
chopped into suitable lengths, spheronised and dried to form
the core particles of the formulation. These granules were
coated with different polymers according to the formulae dis-
cussed in Table 3. The sieved core particles were rotated in a
small coating pan and the coating mixture was added in por-
tions by a spray gun (pressure 30 kg/cm2; nozzle size 1 mm)
to the pan up to 5% w/w increase in the granules weight. After
each addition of coating mixture, air was blown into the pan at
a temperature of 60 C to assist in solvent removal. At the end
of the addition of the coating mixture, the coated core particles
were dried to constant weight and sieved to produce granules
having a size between 0.8 and 1.2 mm.
2.2.4. Preparation of microparticles
2.2.4.1. Compression method. The lacidipine microparticles
were prepared using different formulae as shown in Table 4,
which included the formation of slugs (10 mm) by tablet press
and then passing them through a sieve (60 mesh) to obtain
microparticles.
(i) Preparation of slugs: Weighed quantity of lacidipine
(0.5%) and tween 80 (0.2–0.4%) was allowed to dissolve
in methanol. The mixture was adsorbed on diluentsnsity granules (per 500 mg granules).
IV V VI VII VIII IX
2 2 2 2 2 2
q.s q.s q.s q.s q.s q.s
20 20 20 – – –
– 3 5 10 – –
– – – – 5 5
– – – – 10 20
1 1 1 1 1 1
q.s q.s q.s q.s q.s q.s
; HPC, hydroxypropyl cellulose.
coated granules (per 500 mg granules).
IV V VI VII VIII IX
50 25 25 25 75 –
– – – 75 25 –
50 75 – – – 25
– – 75 – – 75
q.s q.s q.s q.s q.s q.s
Table 4 Different formulae for the preparation of lacidipine
microparticles.
Composition CF 1 CF 2 CF 3 CF 4
Lacidipine 0.5 0.5 0.5 0.5
Lactose q.s – – –
Mannitol – q.s q.s q.s
BaSO4 – – – 50
DCP 10 – 50 –
SCMC – 20 20 20
HPMC – – 20 20
Magnesium stearate 1.0 1.0 1.0 1.0
Tween 80 0.2% 0.4% 0.4% 0.4%
All ingredients were expressed in % w/w.
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ferent ratios and passed through a 30 mesh sieve to form
granules. The granules were then mixed with a lubricant
(magnesium stearate; 1%) and ﬁnally compressed to
250 mg tablets using 10 mm punches.
(ii) Preparation of microparticles: The prepared slugs were
passed through a 60-mesh sieve to form microparticles
and ﬁnally ﬁlled into capsules for in vitro dissolution.
This batch was coded as F-CF.
2.2.4.2. Ionic gelation with tripolyphosphate. The chitosan
microspheres were prepared with TPP by ionic crosslinking
by the method described by (method A) (Ko et al., 2002).
An attempt was made to improve the rigidity of the formula-
tion by cross-linking of the prepared microspheres with glutar-
aldehyde (method B) (Table 5).
Method A: The drug (2 mg) was dissolved in methylene
chloride (2:10) due to its water insoluble behavior. This organ-
ic phase was mixed with aqueous phase (5 mL) containing 4%
w/v chitosan solution in acetic acid (2% v/v) by continuous
stirring for 20 min. O/W emulsion was sprayed onto 20 mL
of TPP solution (10% w/v) with continuous stirring using a
spray gun having a pressure of 40 kg/cm2 with a nozzle size
of 1 mm. After the cross linking time (60 min), the chitosan
microspheres were washed with distilled water repeatedly, ﬁl-
tered through a Whatman ﬁlter paper (No. 542, pore size
2.7 mm) and allowed to dry in a vacuum desiccator for 24 h
at room temperature. The batch was coded as F-TPP.
Method B: In this method ionic gelation with TPP is com-
bined with stepwise crosslinking with glutaraldehyde. Micro-
spheres obtained by method A were further dipped in
glutaraldehyde (2.5% w/v, 10 mL) for 8 h. The microspheres
were collected over Whatman ﬁlter paper (No. 542, pore size
2.7 mm), washed (with distilled water to remove excess of glu-
taraldehyde) and dried at room temperature (37 C) for 24 h in
a vacuum desiccator. This formulation was coded as F-TPG.Table 5 Methods for cross linking of chitosan TPP
microspheres.
Method Formulation
code
Formulation
Method A TPP Ionic gelation with TPP
Method B TPG Ionic gelation combined with step-wise
cross linking with glutaraldehyde2.2.4.3. Spray drying. The chitosan micropsheres were pre-
pared by the spray drying technique. The chitosan solution
to be spray dried was prepared by dissolving chitosan (0.5%
w/v) in deionized water containing acetic acid (2% w/v).
Lacidipine (100 mg) was dissolved in methylene chloride
(10 mL) and then dispersed in a polymer solution by continu-
ous stirring on a magnetic stirrer (1000 rpm) for 15 min.
Glutaraldehyde solution (7.5 mL, 1% w/v) was added as a
cross-linking agent to the above solution and stirred again
for 10 min. Then the solution was sprayed dried by a mini
spray drier (Table top model, SM Scientech, Mumbai, India)
using an inlet temperature of 120 C, outlet temperature of
80 C with spray ﬂow at a rate of 1.2 ml/min and a pressure
of 50 kg/cm2. This batch is denoted by code F-SD.
2.2.4.4. Ionotropic gelation with CaCl2. A sodium alginate solu-
tion (6% w/v) was prepared by dissolving a weighed amount of
sodium alginate in warm water (60 C) with continuous stir-
ring. After thorough mixing, the solution was kept for 20–
30 min in order to make the solution bubble-free. In another
ﬂask, lacidipine (2 mg) was dissolved in methylene chloride
(2.5 mL) and then the drug solution was allowed to disperse
in a polymer solution (5 mL) by continuous stirring for
10 min. The resulting drug polymer solution was then sprayed
onto 50 mL of cross-linking solution containing calcium chlo-
ride solution (10% w/v), chitosan (1% w/v solution in 2% ace-
tic acid) and tween 80 (0.1% w/w). The solution was atomized
through a spray gun having a nozzle size of 1 mmmaintained at
a pressure of 40 kg/cm2 by an oil free air compressor piston.
After the formation of sodium-alginate microcapsules, the sus-
pension was kept in freezer at 8 C for 12 h for solidiﬁcation.
The formed microparticles were then ﬁltered through What-
man ﬁlter paper (No. 542, pore size 2.7 mm), washed twice with
distilled water and allowed to dry in a vacuum desiccator for
24 h at room temperature. The batch is referred to as F-CC.
2.2.5. Particle size analysis
The average particle size was measured using an optical micro-
scope with a calibrated ocular micrometer. 100 particles of
each formulation were measured for analysis.
2.2.6. Morphological characterization
The shape and surface characteristics of the microparticles
were followed by a scanning electron microscope (JSM 5610
LV SEM, JEOL, Datum Ltd., Japan) chamber in which sam-
ples of the microcapsules were dusted onto a double-sided tape
on an aluminum stub. Afterwards, the coating was performed
with gold using a cool sputter coater (Polaran E 5100) to a
thickness of 400 A0. Photomicrographs were taken at the
accelerated voltage of 20 kV and a chamber pressure of
0.6 mmHg.
2.2.7. Drug content of microparticles
Drug entrapment for microparticles was determined by the
method previously reported with a slight modiﬁcation (Sultana
et al., 2009). Accurately weighed quantity of microparticles
(50 mg) were crushed in a glass mortar-pestle and suspended
in 10 mL of methanol. The suspension was sonicated (bath
sonicator) for 30 min and ﬁltered through a 0.22 lm Millipore
ﬁlter. The ﬁltrate was analyzed for drug content at 241.5 nm
spectrophotometrically.
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The optimized formulations prepared by different methods
were evaluated for in vitro release by USP dissolution appara-
tus 2 (paddle apparatus), using 900 mL of the dissolution med-
ium (0.1 N HCl, pH: 1.2) and containing 1% PEG 400 as
solubilizing agent. The rotating speed was adjusted to
50 rpm. At predetermined time intervals 10 mL sample was re-
moved and the same sample was replaced with fresh medium.
The samples were ﬁltered using Millipore ﬁlter (0.22 lm)
assembly and the drug content was estimated spectrophoto-
metrically at 241.5 nm.
2.2.9. In-vitro bioadhesion
The mucoadhesive property of the prepared microparticles was
evaluated by an in vitro adhesion testing method known as
wash-off method as reported previously by Sultana et al.
(2009). A constant number of microspheres (50) were spread
onto rat stomach mucosa tied onto the glass slide using a
thread. The prepared slide was hung onto one of the groves
of a USP tablet disintegrating test apparatus and was given
up and down movements for 1 h in the beaker of the disinte-
gration test apparatus containing the gastric ﬂuid (pH 1.2).
At the end of the experiment, the number of microparticles still
adhering to the tissue was counted. % bioadhesion was deter-
mined by the following formula:
Percent bioathesion ¼ No of athered microparticles
No of applied microparticles
 100Figure 1 Lacidipine loaded sucrose beads prepared by (a) adsorption
adsorbed on the beads; (1a) individual beads containing the adsorbed d
polymeric solutionwas coatedover the bead in a coatingpan; (1b) individua2.2.10. Drug release pattern from microspheres
Different kinetic equations like zero order (% release vs t), ﬁrst
order (log% release vs t) and Higuchi model (% release vs
square root of time) were applied and R2 values were calcu-
lated for the linear curves obtained by regression analysis of
the above plots. In order to deﬁne a better release mechanism,
the experimental data were further analyzed by Peppas equa-
tion, Qt/Qx= Ktn, where Qt/Qx was the fraction of drug re-
lease at time t, K was the kinetic constant and n (diffusional
exponent) values could be obtained from the slope of a plot
of log Qt/Qx vs log time.
2.2.11. High density potential test
A constant number of particles (50) were added in a beaker
containing 20 mL of glycerol (100 mL, 1.261 g/cm3) as a med-
ium placed on a magnetic stirrer. The speed of stirring was ad-
justed to 50 rpm. The time of settling of microparticles and the
total number of particles settled in glycerol were noted by vi-
sual inspection.
3. Results and discussion
3.1. Polymer coated sucrose beads
The high density sucrose beads were used to target lacidipine
directly to the pylorus. As these beads showed immediate drug
release (solubilizes within few seconds), it required polymericmethod in which 2% SCMC and Eudragit ethanolic solution was
rug; (2a) zooming of the bead surface (b) coating method in which
l bead containing the adsorbeddrug; (2b) zoomingof the bead surface.
Figure 2 Release proﬁle of lacidipine loaded sucrose beads
prepared by coating of different polymeric compositions in a
coating pan by using a spray gun.
298 S. Sultana et al.coating which was able to retard the drug release. Different
polymers/combinations (Table 1) were tested to fulﬁll the de-
sired target. SEM photomicrograph of the sucrose bead
showed a spherical shape with approx 1 mm size. The drug
and polymer particles adsorbed on its surface can be clearly
visible in the images (Fig. 1a and b). Fig. 1c revealed a smooth
surface of the coated bead free from any cracks or imperfec-
tions. As shown in Fig. 2, release by this method could not ex-
tend more than 40 min which was attributed to high solubility
of sucrose in the release medium (0.1 N HCl). Thus the method
was dropped meanwhile and not further continued.
3.2. Granules
The granules were prepared by wet granulation technique
according to the formulae given in Table 2. Granulation is a
process in which particle components are held together by
the chemical bonds of inﬁnite strength (Radhika et al.,
2009). This granulation process was carried out for two pur-
poses, ﬁrstly to densify the mass containing drug and to in-
crease the content uniformity as the dose is very small.
Sustained effect can be achieved by the addition of certain
polymers as a binder. The results of dissolution studies shown
in Fig. 3 indicated that the formulation F-I, containing 20%
HPC released 97.98% of the drug in about half an hour
(Fig. 3a). Ethylcellulose has been used as a release retardant
polymer in controlled release dosage form (Roni et al.,
2009). Because of its hydrophobic nature, it reduces the pene-
tration of the solvent molecules into the system. Thus the re-
lease rate can be governed by the permeability of the matrix
system by solvent molecules (Zarzycki et al., 2010). Ethyl cel-Figure 3 Release proﬁle of lacidipine loaded granules containlulose addition in the above formulation favored sustained ef-
fect with 81.29% (F-II), 55.98% (F-III) and 55.98% (F-IV)
release at the end of 45 min (Fig. 3a).
Eudragit is a copolymer of acrylic and methacrylic acid es-
ters, which is usually supplied as an aqueous dispersion con-
taining approximately 30% solids. It is employed for several
oral dosage forms allowing controlled release throughout the
whole GIT when embedded in a matrix system. A formulation
containing 10% Eudragit (F-VII) released 81.33% drug in
1.5 h when compared with F-V and F-VI containing 3% and
5% Eudrajit, respectively (Fig. 3b). Incorporation of a high
concentration of Eudragit produces a more controlled effect,
which is attributed to decreased penetration of the solvent in
a matrix system containing the hydrophobic polymer, which
consequently decreases the diffusion of the drug molecule.
The formulations F-VIII and IX containing 10% and 20%
HPC, release 100% drug within 60 min (Fig. 3b).
3.3. Coated granules
The sustained effect could not be achieved simply by the gran-
ulation process. After drug administration, the contents of the
core of each granule are thought to dissolve quickly. This
makes coating of polymeric solutions (preferably hydrophobic
in nature) onto the granules mandatory to design the con-
trolled release system. It is thought that polymeric coating
around the core limits the subsequent release of the compo-
nents of the core and, hence, produces the controlled sus-
tained-release shown by the formulation.
As shown in Fig. 4a, when the granules were coated
employing the mucoadhesive polymer alone (F-I), the release
could not be sustained for more than 4 h. Whereas when eth-
ylcellulose was incorporated along with the mucoadhesive
polymer, the granules were found to be intact over a period
of 6 h due to water insoluble nature of ethyl cellulose and
the lacidipine release was spread over a longer period of time.
When compared with ethyl cellulose concentration, the release
was relatively faster with F-II (99.28% in 240 min) containing
15% ethyl cellulose than F-IV (99.82% in 6 h) possessing 75%
ethyl cellulose. Formulation (F-VI) containing 25% HPC and
75% HPMC released 100% of the drug within 4 h. This burst-
ing effect may be due to fast erosion of the two polymers in a
dissolution medium that creates pores through which rapid dif-
fusion of drug molecules is quite possible. Furthermore, to
potentiate the mucoadhesive and sustained effect of granules,
combinations of Eudragit and hydroxypropylcellulose wereing different proportions of polymeric solution as binders.
Figure 5 Schematic representation of different methods for the preparation of lacidipine loaded microparticles.
Figure 4 Release proﬁle of lacidipine loaded granules coated with different proportions of polymeric solution.
Table 6 Physicochemical characteristics and entrapment efﬁciency of microspheres prepared by different methods.
Formulation code Particle size (lm± SD)* Entrapment eﬃciency (%± SD) Bioadhesion (%± SD)
F-GC 1420 ± 0.76 mm 100 4.23 ± 0.58
F-CF4 51.76 ± 0.12 100 8.33 ± 0.32
F-TPP 46.22 ± 0.86 87.68 ± 0.78 52.67 ± 1.15
F-TPG 39.37 ± 0.63 87.68 ± 0.78 46.33 ± 1.53
F-SD 63.33 ± 0.45 11.65 ± 0.92 46.67 ± 3.05
F-CC 88.57 ± 0.51 78.58 ± 0.85 67.33 ± 1.53
GC, wet granulation with coating; CF4, indicates compression method; TPP, tripolyphosphate; TPG, tripolyphosphate combines with glu-
taraldehyde; SD, spray drying and CC, ionotropic gelation.
* Standard deviation (n= 3).
Lacidipine loaded gastroretentive formulation 299tried. Fig. 4b shows that F-VII (75% Eudrajit) and F-VIII
(25% Eudrajit) release 81.25% and 91.2% drug, respectively,
in 5 h. Thus the combination of polymers and their concentra-
tion must be optimized in order to provide sustain release. The
best sustained effect was attained with formulation F-VII and,
hence, selected for further studies. This batch of formulation
was further coded as F-GC.
3.4. Microparticles
The microparticles prepared by compression method (slugging
process), glutaraldehyde crosslinking, ionic crosslinking with
TPP, spray drying, and ionotropic gelation with calcium chlo-ride were compared for particle size, surface morphology, %
yield, entrapment efﬁciency, in vitro drug release and% bioad-
hesion. Fig. 5 showed schematic representation for the prepa-
ration of different types of microparticles. The results of
evaluation for different formulations are shown in Table 6.
3.4.1. In vitro release study
Microparticles prepared by compression method were opti-
mized on the basis of dissolution rate. Comparative drug re-
lease proﬁles of different formulations were given in Fig. 5.
The percent drug release from Formulation CF-1 was found
to be only 41.26% after four hours due to the poor solubility
of lacidipine in 0.1 N HCl. In order to improve the dissolution
Figure 6 Comparative release proﬁle of marketed formulation
(CM) and microparticles prepared by the compression method
(CF).
Figure 7 Comparative release proﬁle of microparticles prepared
by different methods: TPP ionotropic gelation of chitosan with
TPP; TPG stepwise crosslinking with gluatarldehyde; SD spray
drying; CC ionotropic gelation with calcium chloride and
chitosan.
300 S. Sultana et al.rate of lacidipine, formulation CF-2 was prepared by replacing
lactose with mannitol, which was used as a diluent. The SCMC
was included in this formulation as a mucoadhesive polymer.
This time there was an increase in the dissolution rate of lacid-
ipine and release in 1 h was found to be 81.53%, which was de-
sired. It has been reported that the combination of HPMC and
SCMC was found to affect bioadhesion strength and drug re-
lease (Rathi et al., 2012). Based on these observations, further
formulation (CF-3) was modiﬁed by incorporation of HPMC
K4 100 as a mucoadhesive polymer. Although, the release
was 91.33% at this time, the microparticles were ﬂoated in
the dissolution medium. To make them sink to the bottom
of the ﬂask, dicalcium phosphate was replaced with barium
sulfate, a well known high density diluent in formulation
CF-4. This time the microparticles remained at the bottom
of the ﬂask, which was desirable.
The technique enhanced the dissolution of lacidipine, which
was poorly soluble (0.47 lg/ml) with an aim of targeting di-
rectly to pylorus with the controlled release of active medica-
ment. A 100% yield without any loss of drug was obtained.
Although the dissolution rate was enhanced from 44.6% (F-
CM: marketed formulation) to 84.33% (CF-4: microparticles),
poor release characteristics (84.33% in 2 h) were a main draw-
back associated with this method (see Fig. 6).
TPP is nontoxic and consists of multivalent anions which
can form gel by ionic interaction with positively charged amino
group of chitosan (SzymaSka and Winnicka, 2012). Ko et al.
reported an increased probability of interaction of TPP with
a higher concentration of chitosan (Ko et al., 2002). As a result
strong walled microparticles having better entrapment efﬁ-
ciency and slow release characteristics could be obtained.
Microspheres prepared by this method have a very poor
mechanical strength that can be explained by their preparation
method. The OH- ions compete with tripolyphosphosphoric
ions (P3O
5
10 ) to react with protonated amino group of chitosan
present on the surface of chitosan particles. After the forma-
tion of an outer layer, because of small size, OH ions possess
a higher ability to permeate through the gelled layer into the
inside matrix than P3O
5
10 ions. As a result, the cross-linking
process was greatest on the chitosan droplet surface, and it de-
creased toward the center, resulting in poor mechanical
strength (Park et al., 2002; Bodmeier and Paeratakul, 1989).
As a result microparticles were more easily deformed in wash-
ing and drying steps. This drawback can be overcome by uti-
lizing a stepwise cross-linking method with glutaraldehyde
(GTA). It is noteworthy that the release proﬁle was greatly im-
proved when TPP ionic gelation was adopted before GTAcrosslinking (Wang et al., 2006). The release of the lacidipine
from the chitosan matrix involved initial swelling followed
by diffusion of the drug molecules (kumar et al., 2012).
Fig. 7 showed that a signiﬁcant decrease in drug release was
observed after stepwise cross-linking. Formulation TPP re-
leased 81.4% drug while TPG released only 54.85% in 6 h.
Obviously both faster and high burst rates were observed when
microparticles were prepared without GTA. As shown the re-
lease was greatly improved with reduced burst effect when the
same particles were further cross-linked with GTA. This fact
was due to the large amounts of amino groups (NH2) on
chitosan that had been consumed by TPP and glutaraldehyde
that allowed lacidipine to diffuse steadily. Furthermore, the
structure of lacidipine-loaded microspheres was tightly packed,
that retarded the diffusion of drug. These results are further
supported by Sun et al. where release was observed for
>48% after modifying GTA concentration (Sun et al., 2010).
Particles obtained by a spray drying process followed by a
chemical treatment with glutaraldeyde showed 98.64% drug
release at the end of the 5th hour (Fig. 7). These results were
similar to those in the study of He et al. who also reported fast
release, accompanied by a burst effect (He et al., 1999). On the
other side Raval and coworkers reported controlled release for
10 h when 1:2 ratio of drug: polymer was chemically cross-
linked (Raval et al., 2010).
Alginate gel microspheres have been conventionally pre-
pared by ionic interaction of alginate and CaCl2. This ap-
proach has been associated with a certain drawback, namely
poor entrapment efﬁciency which was due to the high porosity
of alginate gel that resulted in loss of the entrapped molecule
during the hardening and washing process; low stability of
beads such as Ca2+ that could be removed by the chelating
agents or high concentration of ions such as Na+, Mg2+. As
Ca2+ was removed from gels, cross-linking diminishes and
facilitated gel erosion which ultimately led to the loss of the en-
trapped materials (Onishi et al., 2010). These disadvantages
can be overcome by the incorporation of polycations such as
chitosan in the encapsulation medium strengthening the algi-
nate beads and thus reducing drug loss (Sultana et al., 2012).
The same system will reduce porosity and improve the stability
of the capsule (Batubara1 et al., 2012). The interaction of
chitosan and alginate results in the formation of such a dense
matrix system that is expected to settle down near the pylorus.
In vitro release studies showed that the drug was released from
Figure 8 Scanning electron microscope photomicrograph of microparticles prepared by compression method (a) zoomed (b)
microparticles showing clumping and irregular shaped surfaces.
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more than 7 h. Similar sustained effect up to 12 h through
the optimization of chitosan and alginate concentration was
observed by previous researchers (Arora and Budhiraja, 2012).
3.4.2. Particle size analysis
Granulation technology yielded lacidipine loaded granules of
average size of (F-GC) of 1.42 ± 0.76 mm. Average size of
microparticles prepared by the compression method (F-CM)
was 51.76 ± 0.12 lm (Table 6). The average particles size of
formulation F-TPP was 46.22 ± 0.86 lm. The particle size
was decreased from 46.22 ± 0.86 (method A) to 39.37 ±
0.63 lm (method B) when the same microparticles (F-TPP)
were cross-linked with glutaraldehyde which was due to an in-
crease in shrinking during the cross-linking process. The parti-
cles prepared by spray drying and coacervation processes were
small with an average size of 63.33 ± 0.45 and
88.57 ± 0.51 lm, respectively.
3.4.3. Drug content
Entrapment efﬁciency was 100% in the case of particles pre-
pared by granulation technology and compression method as
no loss occurred at any stage of processing. The particles pre-
pared by ionotropic gelation process with TPP showed excel-
lent entrapment efﬁciency (87.68%± 0.78). Previous
researchers reported 78.5% entrapment efﬁciency when 5-ﬂuo-
rouracil loaded micropsheres were prepared by a two step solid-
iﬁcation process (24). However, 11.65 ± 0.92% entrapment
efﬁciency was observed in particles prepared by spray drying
technique which was attributed to the low yield of the particles
(12.23%). These results were in agreement with the previous
data reported by Desai and Park, where 39.3–45.8% yield of
microparticles was observed with the spray drying process
(Desai and Park, 2005). Entrapment efﬁciency was found to
be 78.58% for the particles prepared by the coacervation pro-
cess using CaCl2 and chitosan as a crosslinker. Similarly, high
entrapment efﬁciency, i.e., 84% was reported by previous
researchers when microparticles were formulated using 2% w/
v alginate, 0.75% w/v chitosan (pH 5.0), and 1.0% w/v calcium
chloride concentration (Arora and Budhiraja, 2012).
3.4.4. Morphological characterization
SEM photomicrographs of particles prepared by compression
method are shown in Fig. 8. The particles are irregular in
shape with varying size distribution. Micropheres preparedby ionotropic gelation with TPP were rounded with irregular
surfaces (Fig. 91a). In fact some images showed a clumping
of particles (Fig. 92a). However well deﬁned change in surface
morphology was observed when the same particles were fur-
ther cross-linked with glutaraldehyde. In this instance, micro-
particles were well rigidized with free ﬂowing characteristics
(Fig. 9b). SEM photomicrographs showed that spherical
microspheres with smooth surfaces were obtained by the spray
drying technique (Fig. 9c). The particles prepared by ionotro-
pic gelation with CaCl2/coacervation mechanism were spheri-
cal, discrete with smooth surfaces (Fig. 9d).
3.4.5. In-vitro bioadhesion
As shown in Table 5, least mucoadhesions i.e., 4.23 ± 0.58%
and 8.3 ± 0.32% were observed by the particles prepared by
the granulation method (GM) and the compression method
(CM). This is due to the presence of large amounts of excepi-
ents (like diluents, barium sulfate, and magnesium stearate)
other than mucoadhesive polymers. The formulation F-TPP
showed 52.67% mucoadhesion. Chitosan possess protonated
amino groups which can interact with several negatively
charged surfaces of mucin. It was found that bioadhesion
was decreased from 52.67% (Method A; F-TPP) to 46.33%
(Method B; F-TPG) depending upon the method of cross-
linking which was due to the consumption of amino groups
of chitosan by glutaraldehyde when stepwise cross-linking
was employed. This decreased the availability of the free amino
group to cross link with mucin. TPP ionic gelation combined
with step-wise cross-linking with GTA resulted in micro-
spheres having good mechanical strength with decreased bio-
adhesion. 46.67 ± 3.05% bioadhesion was observed when
the chitosan microparticles were prepared by the spray drying
method. In vitro wash off method showed 67.33% mucoadhe-
sion for the formulation prepared by coacervation (F-CC)
which was attributed to the fact that alginates had hydrogen-
bonding groups (OH and COOH) that favored chemical
bond formation at the mucin surface. The bioadhesion prop-
erty of these microparticles can result in prolonged retention
in the stomach mucosa and selectively release the drug at its
target site.
3.4.6. Drug release pattern from microparticles
The drug release data of different microparticles were extrap-
olated by zero order, ﬁrst order, Higuchi and Korsmeyer–Pep-
pas equations to predict the mechanism of drug release and
the results are shown in Table 7. The in vitro release proﬁle
Table 7 R2 and n values for selected formulations.
Formulation code Zero order First order Higuchi Peppas n Mechanism of drug release
F-GC 0.9607 0.9451 0.9848 0.9925 0.2941 Fickian release
F-CF4 0.9855 0.9623 0.9965 0.9974 0.4552 Fickian release
F-TPP 0.9694 0.87 0.9954 0.9972 0.4179 Fickian release
F-TPG 0.9585 0.8932 0.9924 0.9965 0.3466 Fickian release
F-SD 0.9491 0.8415 0.9899 0.9911 0.6248 Non-Fickian release
F-CC 0.9563 0.8339 0.9932 0.9947 0.7249 Non-Fickian release
F-GC, wet granulation with coating; F-CF4, indicates compression method; F-TPP, tripolyphosphate; F-TPG, tripolyphosphate combines with
glutaraldehyde; F-SD, spray drying and F-CC, ionotropic gelation.
Figure 9 Scanning electron microscope photomicrograph of microparticles prepared by different methods: (a) TPP: ionotropic gelation
of chitosan with TPP; (b) TPG: stepwise crosslinking with gluatarldehyde; (c) SD: spray drying; (d) CC: ionotropic gelation with calcium
chloride and chitosan.
302 S. Sultana et al.
Table 8 High density test for selected formulations.
S. No. Formulation code Particles settled (%± S.D*) Settling time (s)**
1 F-GC 100 ± 0.00 5
2 F-CF4 96.67 ± 1.154 6
3 F-TPP 92.0 ± 2.00 7
4 F-TPG 95.33 ± 1.154 4
5 F-SD 70.0 ± 4.00 11
6 F-CC 96.67 ± 2.31 9
F-GC, wet granulation with coating; F-CF4, indicates compression method; F-TPP, tripolyphos-
phate; F-TPG, tripolyphosphate combines with glutaraldehyde; F-SD, spray drying and F-CC,
ionotropic gelation.
* Standard deviation (n= 3).
** Time of settling of particles in second.
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tion, as the plots showed highest linearity (R2: 0.98–0.99). The
mechanism involved the absorption of water into the hydro-
philic polymer matrix and the diffusion of drug molecules into
the medium. To explore the diffusion mechanism, the data
were further ﬁtted into the Korsmeyer–Peppas equation. The
formulations showed good linearity (R2: >0.99) with slope
(n) values ranging from 0.29 to 0.46 indicating Fickian diffu-
sion as a mechanism for different formulations from the com-
pression method and ionotropic gelation with TPP. Fickian
diffusional release occurs by the molecular diffusion of the
drug molecule driven by a chemical potential gradient, while
formulations SD and CC showed high linearity with slope val-
ues >0.6, which indicated non-ﬁckian diffusion as a predom-
inant release mechanism. The same system favored polymer
disentanglement with erosion due to swelling of the hydro-
philic glassy polymers (Maggi et al., 2002).
3.4.7. High density potential
Due to the high density of glycerol, it was selected as the med-
ium for analyzing the high density potential of the formula-
tion. It was also expected that the density of the chyme in
the stomach could not extend to that of glycerol. The result
of the high density study is shown in Table 8. All formulations
were settled in the glycerol within 4–11 s. The particle settle-
ments ranged from 70.0% to 100%, respectively, depending
upon the preparation method.
4. Conclusion
Different formulations of lacidipine were prepared keeping in
mind the density, high entrapment and high mucoadhesive po-
tential. The high density sucrose bead was not able to maintain
its release proﬁle for more than 40 min. Granulation technol-
ogy in fact was unable to provide a once daily lacidipine dos-
age regimen for gastroparesis. Therefore, the granules were
coated with different polymers. The coating polymers granules
can be manipulated in order to formulate an optimistic formu-
lation. But the formulation F-GC lacks mucoadhesive poten-
tial which might be due to its large size and the presence of
other ingredients (diluents). The formulation prepared by ionic
gelation with TPP (F-TPP) has poor mechanical strength, rel-
atively fast release and low mucoadhesive potential when com-
pared with others (F-CC). The formulation can be cross-linkedwith glutaraldehyde to overcome these drawbacks. This addi-
tional solidiﬁcation step to improve mechanical strength left
this procedure tedious and time consuming. Moreover, rigidi-
zation with GLA, further reduces the mucoadhesive potential
and increases the cytotoxicity of the formulation. The formu-
lation prepared by spray drying produced small and spherical
particles, but relatively suffered from low yield. Moreover, glu-
taraldehyde was added as a cross-linker, make it unsuitable for
in vivo utility. The formulation F-CC (coacervation process)
was found to be best owing to its surface properties, sustained
effect and its comparatively high mucoadhesive potential.
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